The U.S. Department of Justice has sent a subpoena to medical device maker Medtronic Inc. as part of an investigation into unapproved, or “off-label,” uses of its Infuse spinal graft. Bill Hawkins, chief executive for Minneapolis-based Medtronic, revealed the subpoena during a Tuesday conference call with analysts, but he declined to elaborate on what was requested.
